Lock-Up AgreementLock-Up Agreement • February 14th, 2020 • Wang Xuezhu • Medicinal chemicals & botanical products • New York
This Lock-Up Agreement (this “Agreement”) is being delivered to Univest Securities, LLC (the “Representative” in connection with the proposed Underwriting Agreement (the “Underwriting Agreement”) between Happiness Biotech Group Limited, a Cayman Islands company (the “Company”), and the Representative, as the representative of the several underwriters listed in Schedule A thereto (the “Underwriters”), relating to the proposed public offering (the “Offering”) of ordinary shares, par value $0.0005 per share (the “Ordinary Shares”), of the Company.
Joint Filing AgreementJoint Filing Agreement • February 14th, 2020 • Wang Xuezhu • Medicinal chemicals & botanical products
The undersigned agree that this Schedule 13D, and any amendments hereto, relating to the Ordinary Shares of the Issuer shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13D.
JOINT FILING AGREEMENTJoint Filing Agreement • July 28th, 2023 • Wang Xuezhu • Medicinal chemicals & botanical products
In accordance with Rule 13d-1(k) promulgated under the U.S. Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other reporting persons on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the Class B original share, par value $0.01 per share, of Paranovus Entertainment Technology Ltd., and that this Agreement may be included as an Exhibit to such joint filing. This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.
